FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - PlanDefinition

323 resources

Type: Text:

By Version

By Authority

By Realm

 

Prev Rows 200 - 323

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuth
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTMeningococcalQuad2IMMZ.D2.DT.Meningococcal.Quadrivalent conjugate vaccines 2 dosesdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTMumps2DoseIMMZ.D2.DT.Mumpsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTPneumococcal2p1bIMMZ.D2.DT.Pneumococcal.2 doses with booster dosedraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTPneumococcal3p0bIMMZ.D2.DT.Pneumococcal.3 dosesdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTPolioBirthIMMZ.D2.DT.Polio.Birth dosedraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTPolioIPVIMMZ.D2.DT.Polio.IPV-onlydraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTPolioSequentialIMMZ.D2.DT.Polio.Sequential IPV–bOPVdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTPoliobOPVIPVIMMZ.D2.DT.Polio.bOPV plus IPVdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTRabiesPrEPIMMZ.D2.DT.Rabiesdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTRotavirusIMMZ.D2.DT.Rotavirusdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTRubellaHighIMMZ.D2.DT.Rubella.High incidencedraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTRubellaLowIMMZ.D2.DT.Rubella.Low incidencedraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTSeasonalinfluenza2DoseIMMZ.D2.DT.Seasonal influenzadraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTBEEnceVirIMMZ.D2.DT.TBE.EnceVirdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTBEEncepurIMMZ.D2.DT.TBE.Encepurdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTBEFSMEIMMZ.D2.DT.TBE.FSME-Immundraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTBEMoscowIMMZ.D2.DT.TBE.TBE-Moscowdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTyphoidTCVIMMZ.D2.DT.Typhoid.TCVdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTyphoidTy21aIMMZ.D2.DT.Typhoid.Ty21adraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTTyphoidVIPSIMMZ.D2.DT.Typhoid.ViPSdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTVaricella1DoseIMMZ.D2.DT.Varicella.1 dosedraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTVaricella2DoseIMMZ.D2.DT.Varicella.2 dosesdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTYellowfeverIMMZ.D2.DT.Yellow feverdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTBCGCIIMMZ.D5.DT.BCG contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTDTPCIIMMZ.D5.DT.DTP contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTDengueCIIMMZ.D5.DT.Dengue contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTHPVCIIMMZ.D5.DT.HPV contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTHepatitisACIIMMZ.D5.DT.Hepatitis A contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTHepatitisBCIIMMZ.D5.DT.Hepatitis B contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTHibCIIMMZ.D5.DT.Hib contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTJECIIMMZ.D5.DT.JE contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTMalariaCIIMMZ.D5.DT.Malaria contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTMeningococcalCIIMMZ.D5.DT.Meningococcal contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTMumpsCIIMMZ.D5.DT.Mumps contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTPneumococcalCIIMMZ.D5.DT.Pneumococcal contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTPolioCIIMMZ.D5.DT.Polio contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTRabiesCIIMMZ.D5.DT.Rabies contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTRotavirusCIIMMZ.D5.DT.Rotavirus contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTRubellaCIIMMZ.D5.DT.Rubella contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTSeasonalinfluenzaCIIMMZ.D5.DT.Seasonal influenza contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTTBECIIMMZ.D5.DT.TBE contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTTyphoidCIIMMZ.D5.DT.Typhoid contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTVaricellaCIIMMZ.D5.DT.Varicella contraindicationsdraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD5DTYellowfeverCIIMMZ.D5.DT.Yellow fever contraindicationsdraft2025-08who
smart.who.int.ancR4PlanDefinition/ANCDT02ANC.DT.02 Adolescent HEADSS asessementactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT06ANC.DT.06 Physical symptoms and exam results requiring referralactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT32ANC.DT.32 Tetanus toxoid-containing vaccinationactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT31ANC.DT.31 Flu immunizationactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT29ANC.DT.29 HIV risk counsellingactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT28ANC.DT.28 Gestational diabetes mellitus (GDM) risk counsellingactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT27ANC.DT.27 Pre-eclampsia risk counsellingactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT17ANC.DT.17 Pre-eclampsia, severe pre-eclampsia and hypertension diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT22ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT18ANC.DT.18 HIV diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT19ANC.DT.19 Hepatitis B diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT20ANC.DT.20 Hepatitis C diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT21ANC.DT.21 Syphilis diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT24ANC.DT.24 TB diagnosisactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT23ANC.DT.23 Gestational diabetes mellitus (GDM) and diabetes mellitus (DM) during pregnancy diagnosisactive2025-06uvwho
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTMeaslesSupplementaryIMMZ.D2.DT.Measles.Supplementary dosedraft2025-08who
smart.who.int.immunizationsR4PlanDefinition/IMMZD2DTMeaslesDose0IMMZ.D2.DT.Measles.MCV dose 0draft2025-08who
hl7.fhir.uv.cpgR4PlanDefinition/chf-bodyweight-change-pdCHFBodyWeightChangeactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-bodyweight-pdCHFBodyWeightactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-jvp-pdCHFJVPPDactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-net-io-pdCHFNetIOactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-urine-out-pdCHFUrineOutactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-creatinine-pdCHFCreatininePDactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-egfr-pdCHFEGFRPDactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-o2-sat-pdCHFO2SatPDactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-potassium-pdCHFPotassiumPDactive2024-11uvhl7
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex5-stability-study-protocolStability Monitoring Programactive2024-05uvhl7
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex2-manufacturing-planProcess 1.0active2024-05uvhl7
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex3-drug-specificationSPECIFICATION(S) FOR DRUG PRODUCTactive2024-05uvhl7
eng.fhir.profile.devR4PlanDefinition/esempio-PlanDefinition-ForStrategyProtocollo per il trattamento del paziente scompensato classificato in classe funzionale NYHA I-IIactivehl7
de.netzwerk-universitaetsmedizin.ebm-cpgR5PlanDefinition/COVID19NonVentilatedPatientsDexamethasoneApplicationPlanNo Dexamethasone Application for non-ventilated COVID-19 patientsactive2021-12uvhl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-01Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Considerationdraft2025-08ushl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-02Recommendation #2 - Opioid Therapy Goals Discussiondraft2025-08ushl7
hl7.fhir.uv.cpgR4PlanDefinition/cpg-common-registrationPlanDefinition - CPG Common Registrationactive2024-11uvhl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceCreatinineUrine24h24-hour urine creatinine panelactive2020-02chhl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceElectrolytesSerumBlood electrolyte panel (serum or plasma)active2020-02chhl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServicePotassiumSerumPotassium measurement on in vitro blood serumactive2023-06chhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-panel-blood-electrolyteBlood electrolyte panel (serum or plasma)draft2020-02uvhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-panel-urine24h-creatinine24-hour urine creatinine paneldraft2020-02uvhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-potassium-serumlaboratory service - serum potassium leveldraft2020-02uvhl7
hl7.fhir.uv.pharm-qualityR5PlanDefinition/plandefinition-drug-pq-ex1-validation-protocolDP PROCESS VALIDATIONactive2024-05uvhl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-04-05Recommendations #4 and #5 - Lowest Effective Dosedraft2025-08ushl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-rubella-serumlaboratory service - Rubella IgM quantification on serumdraft2020-02uvhl7
smart.who.int.hivR4PlanDefinition/HIVD4DTHIV.D4.DT TB Screening Decision Tablesdraft2025-07who
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceSodiumSerumSodium measurement on in vitro blood serumactive2023-06chhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-torchTORCH (Toxoplasma, Rubella, Cytomegalovirus, Herpes simplex) serology super-panel, acute, on serumdraft2020-02uvhl7
smart.who.int.ancR4PlanDefinition/ANCDT25ANC.DT.25 Anaemia, iron and folic acid supplementationactive2025-06uvwho
ch.fhir.ig.ch-lab-orderR4PlanDefinition/example-lab-panel-urine24h-creatinine-clearance24-hour urine creatinine clearance paneldraft2020-02chhl7
hl7.fhir.us.ph-libraryR4PlanDefinition/us-ph-plandefinition-namedEvent-exampleUS Public Health PlanDefinition NamedEvent Exampleactive2022-06ushl7
hl7.fhir.us.ecrR4PlanDefinition/plandefinition-ersd-instance-namedEvent-exampleeRSD PlanDefinition Instance NamedEvent Exampleactive2020-12ushl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceCreatinineClearanceRenal Insufficiendy Paneldraft2020-02chhl7
hl7.fhir.us.central-cancer-registry-reportingR4PlanDefinition/plandefinition-central-cancer-registry-reporting-examplePlanDefinition Central Cancer Registry Reporting Exampledraft2020-11ushl7
hl7.fhir.us.medmorph-research-dexR4PlanDefinition/plandefinition-examplePlanDefinition Exampledraft2020-11ushl7
hl7.fhir.us.resp-netR4PlanDefinition/plandefinition-examplePlanDefinition RESP-NET Exampleactive2023-06ushl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabService-eGFRRenal Insufficiendy Panel: Service eGFRdraft2025-01chhl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabService-uACRRenal Insufficiendy Panel uACRdraft2025-01chhl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceRenalInsufficiencyRenal Insufficiency Lab Paneldraft2025-01chhl7
smart.who.int.ancR4PlanDefinition/ANCBANC.B Routine contactactive2021-06uvwho
smart.who.int.ancR4PlanDefinition/ANCS01ANC.S.01 Contact scheduleactive2021-06uvwho
smart.who.int.hivR4PlanDefinition/HIV-Testing-PlanDefinitionPlanDefinition - HiV Testingactive2025-07who
smart.who.int.hivR4PlanDefinition/HIV-A-Registration-PlanDefinitionPlanDefinition - HIV.A. Registrationactive2025-07who
smart.who.int.hivR4PlanDefinition/CareAndTreatmentClinicalVisit-PlanDefinitionPlanDefinition - Care and treatment clinical visitactive2025-07who
smart.who.int.hivR4PlanDefinition/PrEP-visit-PlanDefinitionPlanDefinition - PrEP Visitactive2025-07who
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-toxoplasma-serumlaboratory service - Toxoplasma gondii Ab panel on serumdraft2020-02uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/chf-pathwayCHFPathwayactive2024-11uvhl7
hl7.fhir.uv.cpgR4PlanDefinition/va-ckd-recommendationsVACKDRecommendationsactive2024-11uvhl7
ch.fhir.ig.ch-lab-orderR4PlanDefinition/LabServiceVitaminDserum25-hydroxyvitamin D3 [Moles/Vol]active2020-02chhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-vitamind-serumDosage de la vitamine D dans le sangdraft2020-02uvhl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-06Recommendation #6 - Prescribe Lowest Effective Dose and Durationdraft2025-08ushl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-09Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptionsdraft2025-08ushl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-10-order-signRecommendation #10 - Urine Drug Testing (order-sign)draft2025-08ushl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-10-patient-viewRecommendation #10 - Urine Drug Testing (patient-view)draft2025-08ushl7
fhir.cdc.opioid-cds-r4R4PlanDefinition/opioidcds-03Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapydraft2025-08ushl7
smart.who.int.ancR4PlanDefinition/ANCDT37ANC.DT.37 Intimate partner violence (IPV) first-line support and treatmentactive2025-06uvwho
smart.who.int.ancR4PlanDefinition/ANCDT36ANC.DT.36 Intimate partner violence (IPV) clinical inquiryactive2025-06uvwho
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-cmv-serumlaboratory service - CMV IgM quantification on serumdraft2020-02uvhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-hsv-serumlaboratory service - HSV 1 & 2 IgM on serumdraft2020-02uvhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-hsvt1-serumlaboratory service - serum HSV 1 IgM titer on serumdraft2020-02uvhl7
hl7.fhir.uv.order-catalogR5PlanDefinition/example-lab-service-hsvt2-serumlaboratory service - serum HSV 2 IgM titer on serumdraft2020-02uvhl7